Organon’s Implanon Is First Single-Rod Implantable Contraceptive
This article was originally published in The Pink Sheet Daily
Executive Summary
The etonogestrel implant will be available in conjunction with launch of Organon’s physician training program by the end of August.
You may also be interested in...
Pfizer Ends Asenapine Collaboration With Organon
Akzo Nobel unit will continue development of the Phase III antipsychotic as company moves forward with separation of its coatings and chemical division from its pharma business.
Pfizer Ends Asenapine Collaboration With Organon
Akzo Nobel unit will continue development of the Phase III antipsychotic as company moves forward with separation of its coatings and chemical division from its pharma business.
Akzo Nobel Shareholders To Vote On Organon BioSciences IPO
Dutch company’s planned separation of pharmaceuticals business from chemicals/coatings division is expected to be complete in two to three years.